CanSinoBIO says COVID-19 shot may be less effective over time, booster shot promising

'Booster shot six months later led to a seven times to 10-times increase in neutralising antibody levels'

CanSinoBIO says COVID-19 shot may be less effective over time, booster shot promising

China's CanSino Biologics Inc said the efficacy rate for its single-dose COVID-19 vaccine may fall over time. Reuters photo

Beijing, April 1

China's CanSino Biologics Inc said the efficacy rate for its single-dose COVID-19 vaccine may fall over time although it should still have a rate of 50% or more five to six months after inoculation.

A second shot given to trial participants six months after their first injection could offer substantial protection, Zhu Tao, CanSinoBIO's chief scientific officer, said in an online presentation late on Wednesday.

"A booster shot six months later led to a seven times to 10-times increase in neutralising antibody levels, so we expect in this case efficacy could reach over 90%," Zhu said, though he cautioned more clinical trial data was needed for more precise estimates.

The company in February reported interim data that showed the shot was 68.83% effective at preventing symptomatic COVID-19 disease two weeks after vaccination but the rate fell to 65.28% after four weeks.

The February data reflected a shorter time span after the inoculation, Zhu said.

The vaccine has been approved in China, Pakistan, Hungary and Mexico.

CanSinoBIO is also planning a clinical trial in China for an inhaled version of the vaccine.—Reuters

Top Stories

Covid vaccine for all above 18 from May 1

Covid vaccine for all above 18 from May 1

Need to buy from open market | States, private hospitals to ...

Jaishankar, US Secretary of State Blinken discuss security issues in Afghanistan, Myanmar

Jaishankar, US Secretary of State Blinken discuss security issues in Afghanistan, Myanmar

Blinken spoke with Jaishankar to reaffirm the importance of ...

Stricter curbs in Punjab till April 30

Stricter curbs in Punjab till April 30

Lockdown in Mohali on Ram Navami

No proof young more vulnerable: ICMR

No proof young more vulnerable: ICMR

70% of the patients above the age of 40

Cities

View All